Home / Sensory organs / Nepafenac
ATC S01BC10 · Antiinflammatory Agents, Non-Steroids · updated 2 Nov 2026
Nepafenac shortage
As of 2 Nov 2026, Nepafenac has a reported shortage in 1 of the 16 countries we track (Canada), covering 2 products from 1 company.
Is there a Nepafenac shortage?
Yes. As of 2 Nov 2026, Nepafenac is reported short in 1 of the 16 countries we track: Canada. The earliest expected return is 30 Jun 2027 (Canada). 1 of 2 affected products have no return date.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Novartis NOVN · SIX Swiss
Compared with similar medicines
ATC group S01BC · Antiinflammatory Agents, Non-SteroidsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | ILEVRO (1 bottle of 3 mL) | NOVARTIS PHARMACEUTICALS CANADA INC | 20 Jul 2026 | not given | Active ingredient shortage Shortage of an active ingredient |
| CA | ILEVRO (1 bottle of 3 mL) discontinuation | NOVARTIS PHARMACEUTICALS CANADA INC | not given | 30 Jun 2027 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Nepafenac shortage?
Yes. As of 2 Nov 2026, Nepafenac is reported short in 1 of the 16 countries we track: Canada. The earliest expected return is 30 Jun 2027 (Canada). 1 of 2 affected products have no return date.
When will Nepafenac be back in stock?
Companies expect supply back from 30 Jun 2027 in Canada; Canada: 30 Jun 2027. These are company estimates reported to each authority.
Why is Nepafenac in short supply?
The most common reason reported is: active ingredient shortage. Reasons by product are listed in the table below.
Which companies have Nepafenac shortages?
Novartis.